INSTITUT GUSTAVE ROUSSY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 31224
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 16151
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 15110
 
  
 
C07K PEPTIDES 14122
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 14192
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 367
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 2152

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0036,368 COMBINED VACCINATION/RADIOTERAPY FOR CANCER TREATMENTFeb 20, 16Feb 08, 18[A61K, A61N]
2017/0321,282 IMPROVED TREATMENTS OF CANCER RESISTANT TO TAXOIDSOct 28, 15Nov 09, 17[A61K, C12Q, G01N]
2017/0143,780 COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORSJul 16, 15May 25, 17[A61K, C12N, C07K]
2016/0250,249 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING AUTOPHAGY IN A SUBJECT IN NEED THEREOFOct 03, 14Sep 01, 16[A61K]
2016/0184,399 COMBINED PHARMACEUTICAL COMPOSITIONAug 08, 14Jun 30, 16[A61K, C07K]
2016/0116,480 PROGNOSIS AND PREDICTIVE BIOMARKERS AND BIOLOGICAL APPLICATIONS THEREOFMay 13, 14Apr 28, 16[A61K, G01N]
2016/0068,584 CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROMEApr 22, 14Mar 10, 16[C07K]
2015/0198,602 THERANOSTIC METHOD BASED ON THE DETECTION OF HER2-HER2 DIMERSJul 16, 13Jul 16, 15[G01N]
2015/0030,623 Recombinant Feline Leukemia Virus Vaccine Containing Optimized Feline Leukemia Virus Envelope GeneOct 06, 14Jan 29, 15[C12N, C07K]
2013/0164,327 Adenovirus vaccine vectorsApr 28, 11Jun 27, 13[C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9862931 Adenovirus vaccine vectorsApr 28, 11Jan 09, 18[A61K, C12N, C07K]
9810692 Methods for predicting the sensitivity of a subject to immunotherapyOct 25, 13Nov 07, 17[A61K, G01N]
9726661 Simultaneous detection of cannibalism and senescence as prognostic marker for cancerJul 08, 13Aug 08, 17[C12Q, C12N, G01N]
9702875 Expression of isoform 202 of ERCC1 for predicting response to cancer chemotherapyFeb 21, 14Jul 11, 17[C12Q, G01N]
9682137 Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive propertiesDec 07, 12Jun 20, 17[A61K, C07K]
9636396 Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive propertiesDec 07, 12May 02, 17[A61K, C07K]
9593376 Natural killer p30 (NKp30) dysfunction and the biological applications thereofJun 02, 09Mar 14, 17[C07H, C12Q]
9557333 Methods of treating gastrointestinal sarcoma patients depending on their sB7H6 serum levelSep 20, 13Jan 31, 17[G01N]
9428530 Derivatives of oxazaphosphorines that are pre-activated, use and method of preparationJul 02, 15Aug 30, 16[A61K, A01N, C07F]
9297046 TET2 as a new diagnostic and pronostic marker in hematopoietic neoplasmsMar 21, 12Mar 29, 16[C12Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0031,955 Methods for Treating Mitochondrial Disorders and Neurodegenerative DisordersAbandonedJan 30, 14Feb 04, 16[C12Q, C07K]
2015/0232,932 ANKRD26 AS A MARKER FOR DIAGNOSIS OF THROMBOCYTOPENIASAbandonedSep 17, 13Aug 20, 15[C12Q, G01N]
2015/0133,323 METHOD FOR CHARACTERIZING CIRCULATING TUMOR CELLS, AND USE THEREOF IN DIAGNOSISAbandonedNov 19, 12May 14, 15[C12Q, G01N]
2015/0105,281 Method for the Selection of Serum Biomarkers of Epigenetic Alterations, Particularly of Global Hypomethylation and Their UsesAbandonedApr 17, 13Apr 16, 15[C12Q, G01N]
2014/0341,857 COMBINATION OF ONCOLYTIC ADENOVIRUSES WITH HISTONE DEACETYLASE INHIBITORSAbandonedMay 16, 12Nov 20, 14[A61K]
2014/0329,243 METHOD FOR CHARACTERIZING CIRCULATING TUMOR CELLS, AND USE THEREOF IN DIAGNOSISAbandonedNov 19, 12Nov 06, 14[C12Q]
2014/0120,543 EXPRESSION OF ISOFORM 202 OF ERCC1 FOR PREDICTING RESPONSE TO CANCER CHEMOTHERAPYAbandonedSep 09, 13May 01, 14[C12Q, G01N]
2013/0344,494 MYH10 AS A NEW MARKER OF PATHOLOGIES RESULTING FROM RUNX1 INACTIVATIONAbandonedFeb 23, 12Dec 26, 13[G01N]
2013/0281,313 PROGNOSTIC AND/OR PREDICTIVE BIOMARKERS AND BIOLOGICAL APPLICATIONS THEREOFAbandonedSep 01, 11Oct 24, 13[C12Q, G01N]
8557517 Toll like receptor 4 dysfunction and the biological applications thereofExpiredJul 17, 07Oct 15, 13[C12Q]
2013/0189,248 EGFR INHIBITOR AND ANTIVIRAL AGENT FOR SIMULTANEOUS, SEPARATE OR SEQUENTIAL USE IN THE TREATMENT AND/OR PREVENTION AND/OR PALLIATION OF CANCERAbandonedMar 24, 11Jul 25, 13[A61K]
2013/0130,928 METHODS FOR PREDICTING OR MONITORING WHETHER A PATIENT AFFECTED BY A CANCER IS RESPONSIVE TO A TREATMENT WITH A MOLECULE OF THE TAXOID FAMILYAbandonedApr 08, 11May 23, 13[C12Q]
2012/0283,132 MOLECULAR IN VITRO DIAGNOSIS OF BREAST CANCERAbandonedJul 17, 12Nov 08, 12[C40B]
2012/0277,110 PARP AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCERAbandonedJul 26, 10Nov 01, 12[C12Q, G01N, C40B]
8299233 Molecular in vitro diagnosis of breast cancerExpiredJan 05, 09Oct 30, 12[C07H]
8263344 Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatmentExpiredSep 07, 07Sep 11, 12[G01N]
8129340 Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereofExpiredSep 07, 07Mar 06, 12[A61K]
2012/0004,136 MSH2 AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCERAbandonedMar 19, 10Jan 05, 12[C12Q, G01N, C40B]
2011/0301,110 TRIM33 (TIF1gamma) AS A NEW DIAGNOSTIC MARKER OF CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)AbandonedJun 02, 11Dec 08, 11[A61K, C12Q, G01N, A61P]
8058252 Use of inhibitors of scinderin and/or ephrin-A1 for treating tumorsExpiredDec 28, 06Nov 15, 11[C07H, A01N, C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.